Author

K. Thway

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 5 Research Focus:cell type annotation· 3 Research Focus:differential expression· 3 Approach:experimental assay· 3 Assay:proteomics· 3 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1

Frequent Co-Authors

A. Arthur· 3 shared C. Wilding· 3 shared P. H. Huang· 3 shared R. Jones· 3 shared A. Jenks· 2 shared C. Fisher· 2 shared I. Judson· 2 shared J. Burns· 2 shared

Activity by Year

2018-2023 · peak 3/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Arthur

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Proteomic Features of Adolescents and Young Adults with Soft Tissue Tumours

Y. B. Tam, K. Low, H. PS, M. Chadha, J. Burns, C. Wilding, A. Arthur, T. Chen, K. Thway, A. Sadanandam, R. Jones, P. H. Huang

This study compares proteomic profiles of adolescents and young adults with soft tissue tumours to older adults, identifying age-specific molecular features and potential therapeutic targets.

bioRxiv · Nov 18, 2023Cancer Biology

Proteomic characterisation of Sarculator nomogram-defined risk groups in soft tissue sarcomas of the extremities and trunk wall

M. Chadha, S. Iadecola, A. Jenks, J. Burns, A. Arthur, V. Pankova, C. Wilding, D. Callegaro, D. Strauss, K. Thway, A. Gronchi, R. Jones, R. Miceli, S. Pasquali, P. H. Huang

This study identifies a DNA replication protein signature (SPM6) that improves risk stratification in soft tissue sarcomas when combined with the Sarculator nomogram.

bioRxiv · Nov 14, 2023 · PreprintCancer Biology

Combination EZH2 inhibition and retinoic acid treatment promotes differentiation and apoptosis in rhabdomyosarcoma cells

E. OBrien, C. Tse, I. Tracy, I. Reddin, J. Selfe, J. Gibson, W. Tapper, R. J. Pengelly, J. Gao, E. Aladowicz, G. Petts, K. Thway, S. Popov, A. Kelsey, T. J. Underwood, , Z. S. Walters

This study shows that combining EZH2 inhibition with retinoic acid treatment reduces RMS cell proliferation by inducing apoptosis or differentiation depending on the RMS subtype.

bioRxiv · Jun 12, 2023 · PreprintCancer Biology

Proteomic profiling identifies co-regulated expression of splicing factors as a characteristic feature of intravenous leiomyomatosis

L. Krasny, C. Wilding, E. Perkins, A. Arthur, N. Guljar, A. Jenks, C. Fisher, I. Judson, K. Thway, R. Jones, P. Huang

This study identifies co-regulated splicing factor expression as a defining feature of intravenous leiomyomatosis through proteomic analysis.

bioRxiv · Mar 17, 2022Cancer Biology

The adequacy of tissue microarrays in the assessment of inter- and intra-tumoural heterogeneity of infiltrating lymphocyte burden in leiomyosarcoma

A. T. Lee, W. Chew, M. J. Smith, D. C. Strauss, C. Fisher, A. J. Hayes, I. Judson, K. Thway, R. L. Jones, P. H. Huang

This study evaluates the adequacy of tissue microarrays for assessing TIL burden heterogeneity in leiomyosarcoma and finds that 1-3 cores suffice for ordinal categorization but more are needed for accurate absolute counts.

bioRxiv · Sep 10, 2018Cancer Biology